Do pharmaceutical companies continue to rise in prices in the United States?
[Technology] Do pharmaceutical companies continue to rise in prices in the United States? Drug prices remain central to pharmaceutical companies’ [...]
23andMe Begins Clinical Trial for Their First Drug
Clinical trials have begun for the now-ubiquitous DNA-testing company 23andMe’s new cancer drug. The immuno-oncology antibody, named 23ME-000610, targets solid [...]
China National Insurance System and Pharma Reach Pricing Agreement
Pharma and the Chinese government have reached an agreement resulting in price cuts averaging over 60% for Chinese citizens. The [...]
AI Researchers Portal Launched by National AI Initiative Office
The National AI Initiative Office (NAIIO) has just released the AI Researchers Portal. The portal is designed to help researchers [...]
Prior Authorization Examined from the Health Reporter’s Perspective
Prior authorization is a point of conflict between doctors and insurers in the United States, often dragging patients along in [...]
FDA Approves New Heart Drug by Novartis
Novartis’s genetic drug Levqio was approved by the FDA in December, but hurdles remain for long-term sales. The drug, which [...]
Elevate Podcast Channel: Starting a Career in Medical Affairs
Beginning a new career in medical affairs is the topic of the November episode of the Elevate Podcast Channel by [...]
Prescription Drug Policy, 2021 And 2022: The Year In Review, And The Year Ahead
Prescription Drug Policy, 2021 And 2022: The Year In Review, And The Year Ahead This past year was filled with [...]
2022 Digital Transformation Trends in Healthcare
While the COVID-19 pandemic changed the way healthcare is delivered around the world in 2020, the year 2021 has brought [...]
Looking Forward to 2022, COVID-19 Will Continue to Impact Pharma in Myriad Ways
Looking Forward to 2022, COVID-19 Will Continue to Impact Pharma in Myriad Ways As 2021 began, the pharmaceutical topic arguably [...]
5 insights for improving pharmaceutical market access in Asia-Pacific
In this market access update, Jeff explains that while APAC markets may appear to be particularly complex, market access strategies [...]
AI providing the edge against cancer?
AI providing the edge against cancer? The global R&D pipeline is dominated by potential treatments in oncology and this is [...]
Digital health innovation in 2022: Anticipating healthcare trends ahead of the J.P. Morgan week
We spoke with Tanja Dowe, ahead of the annual J.P. Morgan Health Care Conference 2022, about radical innovation in healthcare, [...]
FDAnews Announces The Biden Administration’s Fda: A Remarkable 2021, What to Expect in 2022 Webinar Jan. 20, 2022
The FDA's recent and upcoming changes WILL make an impact: discover what is ahead and how to prepare for what [...]
Drugs by drone: Good idea?
Drone delivery is still in the starting gate, but with early testbeds showing positive results there's good reason to suspect [...]
Cost Of Medicines: Chief Justice Slams Price Gouging | Ahmedabad News – Times of India
Ahmedabad: The chief justice of the Gujarat high court on Wednesday criticized pharmaceutical companies for price gouging under the ‘shield’ [...]
The 340B Drug Pricing Program
Create your free account to read unlimited documents. Create your free account to continue reading. Create your free account to [...]
With Alnylam in rear view, John Maraganore wants to be a biotech multiplier, matchmaker and mentor
With Alnylam in rear view, John Maraganore wants to be a biotech multiplier, matchmaker and mentor aarmstrong Wed, 01/05/2022 - [...]
Clinical Trial Management System Market size worth $ 1890.4 Million, Globally, by 2028 at 10.90% CAGR: Verified Market Research®
JERSEY CITY, N.J. , Jan. 3, 2022 /PRNewswire/ -- Verified Market Research recently published a report, " Clinical Trial Management [...]
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States | Johnson & Johnson
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the [...]
Dr. Shrividya Iyer, Executive Director, Oncology Global Real World Evidence (RWE) & Us Heor, Eisai
Dr. Shrividya Iyer is a health care researcher currently working on cancer health outcomes research , with a key focus [...]
CDER and CBER Real World Data and Real World Evidence
CDER and CBER Real World Data and Real World Evidence [John Smith] Digital Marketing Expert tart Up and Generic Pharmaceutical [...]
Putting patient perspectives at the heart of kidney cancer research
Putting patient perspectives at the heart of kidney cancer research Kidney cancer is the 14th most common cancer, with approximately [...]
Advancing precision medicine through agile governance
Summary The convergence of Fourth Industrial Revolution technologies, including genome editing and artificial intelligence, are revolutionizing modern medicine. At the [...]
Advancing precision medicine through agile governance – Health Econ Bot
from Brookings: Topics – Health at https://brook.gs/3mUXoVl on January 4, 2022 at 05:18AM By Kevin W. Doxzen, Landry Signé, Diana [...]